Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
medical crawled date : 2022 - 04 - 25 save search
Profound Medical to Participate in the 2022 Bloom Burton & Co. Healthcare Investor Conference
Published: 2022-04-25 (Crawled : 21:00) - biospace.com/
PROF | $7.85 -5.42% -5.73% 17K
|
Health Technology
|
| O: 0.26%
H: 0.13%
C: -0.92%
conference
Beyond Air® Presents Positive Safety and Efficacy Data for Inhaled Nitric Oxide to Treat COVID-19 at ECCMID 2022
Published: 2022-04-25 (Crawled : 15:00) - biospace.com/
XAIR | $1.175 -8.2% -8.94% 610K
|
Technology Services
|
| O: 0.86%
H: 19.86%
C: 11.06%
covid-19 air positive
Todos Medical to Present at the Emerging Growth Conference
Published: 2022-04-25 (Crawled : 15:00) - globenewswire.com
TOMDF | $0.0001 100.0% 14M
|
Manufacturing
|
| O: 3.7%
H: 5.0%
C: -5.0%
conference growth
Global Hip Replacement Implants Market (2022 to 2027) - Featuring Zimmer Biomet Holdings, Smith & Nephew and Stryker Among Others
Published: 2022-04-25 (Crawled : 14:20) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
GMED | $50.75 -0.88% 0.0% 950K
|
Health Technology
|
| O: 0.04%
H: 2.38%
C: 2.3%
CFMS | $2.26 0.44% 0
|
Health Technology
|
| O: -0.02%
H: 0.53%
C: -7.18%
market
Rockwell Medical Announces Completion of Patient Enrollment Ahead of Schedule in Pivotal Phase 3 Clinical Trial of Triferic® in China
Published: 2022-04-25 (Crawled : 14:00) - biospace.com/
RMTI | $1.48 0.0% 220K
|
Health Technology
|
| O: 0.0%
H: 1.43%
C: -2.09%
triferic trial china enroll phase 3
Endonovo Therapeutics Signs Agreement with NAMSA to Develop Reimbursement Strategy for Endonovo Medical Products
Published: 2022-04-25 (Crawled : 13:20) - globenewswire.com
ENDV | $0.0024 158.07% 350K
|
Professional, Scientific, and T...
|
| O: 5.56%
H: 0.0%
C: 0.0%
therapeutics
Nemaura Medical to Present at the Planet MicroCap Showcase 2022
Published: 2022-04-25 (Crawled : 13:00) - biospace.com/
NMRD | $0.1053 -28.78% 820K
|
Health Technology
|
| O: 17.02%
H: 0.52%
C: -2.6%
Polytetrafluoroethylene Global Market Report 2022: Medical Device Industry Fueling Demand for PTFE and Other Fluoropolymers
Published: 2022-04-25 (Crawled : 12:00) - prnewswire.com
DKILF | $126.0 25.48% 640
|
Producer Manufacturing
|
| O: 0.54%
H: 0.0%
C: 0.0%
DKILY | $12.49 -0.07% 340K
|
Manufacturing
|
| O: -4.28%
H: 6.0%
C: 3.47%
device report market
Reprocessed Medical Devices Market to Develop at CAGR of 14.9% During Forecast Period, Says TMR Study
Published: 2022-04-25 (Crawled : 12:00) - prnewswire.com
CTS S | $43.1 -1.6% 0.0% 100K
|
Electronic Technology
|
| O: -2.61%
H: 0.36%
C: 0.15%
market
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets, 2020-2021 & 2026
Published: 2022-04-25 (Crawled : 12:00) - prnewswire.com
ALPMF | $9.594 43.47% 2.2K
|
Health Technology
|
| O: -2.78%
H: 0.0%
C: 0.0%
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.99%
H: 0.0%
C: -0.11%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: 0.0%
MNKKQ | $0.02
|
Manufacturing
|
| O: -2.96%
H: 2.29%
C: -6.57%
ALPMY | $9.46 -1.11% 500K
|
Manufacturing
|
| O: -0.1%
H: 0.35%
C: -0.09%
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: -5.01%
H: 0.0%
C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.67%
H: 0.0%
C: 0.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -1.57%
H: 1.5%
C: 1.39%
BSX | $67.42 -0.8% -0.53% 5.9M
|
Health Technology
|
| O: -4.95%
H: 2.32%
C: 1.9%
BHC | $8.6 -0.69% 0.0% 2.1M
|
Health Technology
|
| O: -3.12%
H: 0.37%
C: 0.19%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -2.17%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -2.01%
H: 0.0%
C: 0.0%
NMRD | $0.1053 -28.78% 820K
|
Health Technology
|
| O: 17.02%
H: 0.52%
C: -2.6%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -1.38%
H: 0.65%
C: 0.46%
device disease
University of Tokyo, Astellas Enter Second Phase of Strategic Partnership for Co-creation of Innovative New Medicines and Medical Solutions
Published: 2022-04-25 (Crawled : 07:00) - prnewswire.com
ALPMF | $9.594 43.47% 2.2K
|
Health Technology
|
| O: -2.78%
H: 0.0%
C: 0.0%
ALPMY | $9.46 -1.11% 500K
|
Manufacturing
|
| O: -0.1%
H: 0.35%
C: -0.09%
partnership solutions
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.